Halozyme Therapeutics shares owned by Oberweis Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oberweis Asset Management
from 13F filings
Historical chart of Oberweis Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Oberweis Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.6M | 96k | 36.96 |
2023-09-30 | $1.9M | 51k | 38.20 |
2023-03-31 | $6.3M | 164k | 38.19 |
2022-12-31 | $8.2M | 143k | 56.90 |
2022-09-30 | $4.6M | 117k | 39.54 |
2022-06-30 | $4.5M | 103k | 44.00 |
2022-03-31 | $4.3M | 108k | 39.88 |
2021-12-31 | $4.2M | 106k | 40.21 |
2021-09-30 | $2.8M | 70k | 40.68 |
2021-06-30 | $3.1M | 69k | 45.40 |
2021-03-31 | $2.9M | 69k | 41.68 |